Adebayo Alonge, co-founder and CEO of RxAll, is a Nigerian entrepreneur whose groundbreaking work in deep technology is revolutionizing the fight against counterfeit pharmaceuticals. Driven by a personal encounter with fake drugs that nearly cost him his life, Alonge teamed up with co-founder Amy Kao to create RxAll, a company leveraging AI-powered nanoscanner technology to identify counterfeit medications and ensure drug quality.
Under his leadership, RxAll has achieved significant milestones, including winning the prestigious Hello Tomorrow Global Challenge in 2019, a competition showcasing deep tech innovations worldwide. The company’s innovative RxScanner technology has become a beacon of hope in regions plagued by counterfeit drugs, with operations expanding across Africa and Asia. RxAll also supports pharmacies through its RxDelivered marketplace, making authenticated medications more accessible and affordable.
Alonge’s journey from pharmacist to tech innovator highlights his vision of using technology to address critical healthcare challenges in underserved regions. His work exemplifies a commitment to saving lives, enhancing healthcare quality, and addressing inequality through innovation
